Novel STAT1 alleles in a patient with impaired resistance to mycobacteria
- PMID: 21057861
- DOI: 10.1007/s10875-010-9480-8
Novel STAT1 alleles in a patient with impaired resistance to mycobacteria
Abstract
Partial defects in interferon (IFN)-γ signaling lead to susceptibility to infections with nontuberculous mycobacteria. The receptors for IFN-α and IFN-γ activate components of the Janus kinase-signal transducer and activator of transcription (STAT) signaling pathway. Some defects in STAT1 mainly affect IFN-γ signaling, thus resulting in mendelian susceptibility to mycobacterial disease (MSMD). MSMD is a severe disease but patients show a favorable response to anti-mycobacterial chemotherapy. Other defects in STAT1 affect both IFN-α and IFN-γ signaling resulting in mycobacterial and lethal viral disease. We report here a patient with two novel STAT1 alleles, which in combination results in a recessive trait with partial STAT1 deficiency and mycobacterial disease. Cells from the patient did respond to mycobacterial antigen, but both the expression of STAT1 and phosphorylation of STAT1 in response to IFN-γ treatment were reduced. This is the first report of a mutation in the N-terminal part of STAT1 involved in causing mycobacterial disease.
Similar articles
-
Novel STAT1 alleles in otherwise healthy patients with mycobacterial disease.PLoS Genet. 2006 Aug 18;2(8):e131. doi: 10.1371/journal.pgen.0020131. PLoS Genet. 2006. PMID: 16934001 Free PMC article.
-
Enhanced osteoclastogenesis in patients with MSMD due to impaired response to IFN-γ.J Allergy Clin Immunol. 2022 Jan;149(1):252-261.e6. doi: 10.1016/j.jaci.2021.05.018. Epub 2021 Jun 24. J Allergy Clin Immunol. 2022. PMID: 34176646
-
Human host genetic factors in nontuberculous mycobacterial infection: lessons from single gene disorders affecting innate and adaptive immunity and lessons from molecular defects in interferon-gamma-dependent signaling.Microbes Infect. 2006 Apr;8(4):1157-66. doi: 10.1016/j.micinf.2005.10.029. Epub 2006 Jan 19. Microbes Infect. 2006. PMID: 16520075 Review.
-
Impaired response to interferon-alpha/beta and lethal viral disease in human STAT1 deficiency.Nat Genet. 2003 Mar;33(3):388-91. doi: 10.1038/ng1097. Epub 2003 Feb 18. Nat Genet. 2003. PMID: 12590259
-
Molecular immunity to mycobacteria: knowledge from the mutation and phenotype spectrum analysis of Mendelian susceptibility to mycobacterial diseases.Int J Infect Dis. 2011 May;15(5):e305-13. doi: 10.1016/j.ijid.2011.01.004. Epub 2011 Feb 16. Int J Infect Dis. 2011. PMID: 21330176 Free PMC article. Review.
Cited by
-
Candidate genes and sequence variants for susceptibility to mycobacterial infection identified by whole-exome sequencing.Front Genet. 2022 Oct 20;13:969895. doi: 10.3389/fgene.2022.969895. eCollection 2022. Front Genet. 2022. PMID: 36338958 Free PMC article.
-
Case Report: Eosinophilic Esophagitis in a Patient With a Novel STAT1 Gain-of-Function Pathogenic Variant.Front Immunol. 2022 Jan 20;13:801832. doi: 10.3389/fimmu.2022.801832. eCollection 2022. Front Immunol. 2022. PMID: 35126392 Free PMC article.
-
A novel STAT1 mutation associated with disseminated mycobacterial disease.J Clin Immunol. 2012 Aug;32(4):681-689. doi: 10.1007/s10875-012-9659-2. Epub 2012 Feb 29. J Clin Immunol. 2012. PMID: 22437822 Free PMC article.
-
Conditional Stat1 ablation reveals the importance of interferon signaling for immunity to Listeria monocytogenes infection.PLoS Pathog. 2012;8(6):e1002763. doi: 10.1371/journal.ppat.1002763. Epub 2012 Jun 14. PLoS Pathog. 2012. PMID: 22719255 Free PMC article.
-
Viral infections in humans and mice with genetic deficiencies of the type I IFN response pathway.Eur J Immunol. 2021 May;51(5):1039-1061. doi: 10.1002/eji.202048793. Epub 2021 Apr 4. Eur J Immunol. 2021. PMID: 33729549 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous